Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Tamiflu
Active Ingredient: Oseltamivir phosphate 98.5mg equivalent to 75mg oseltamivir
Dosage Form: Capsule
New Zealand Sponsor: Roche Products (New Zealand) Limited
Manufacturer: F Hoffmann-La Roche Limited, Basel, Switzerland
Product: Taxotere
Active Ingredient: Docetaxel trihydrate 40mg/mL
Dosage Form: Solution for Concentrate for infusion
New Zealand Sponsor: Aventis Pharma Limited
Manufacturers: Aventis Pharma, Dagenham, Essex, United Kingdom
Aventis Principes Actifs Pharmaceutiques, Guesde, Vitry-sur-Seine, France
Note: This medicine has provisional consent that expires on 23 May 2006.
Dated this 24th day of February 2005.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).